TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) Investor Securities Class Action Lawsuit 10/23/2019

  • If you purchased shares of Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), you have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

March 9, 2020 - An amended complaint was filed. October 23, 2019 - An investor in shares of Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by Zynerba Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: